Skip to main content
Edward Drasby, DO, Neurology, Scarborough, ME


Neurology Scarborough, ME

Parkinson's Center of Maine

Dr. Drasby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Drasby's full profile

Already have an account?

Education & Training

  • Boston Medical Center
    Boston Medical Center2000 - 2002
  • Boston University Medical Center
    Boston University Medical CenterResidency, Neurology, 1998 - 2002
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1997 - 1998
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 1997
  • University of Maine
    University of MaineMA, Literature, 1990 - 1993
  • University of Bridgeport
    University of BridgeportBS, English, 1976 - 1978
  • Nassau Community College
    Nassau Community CollegeAS, Engineering, 1971 - 1973
  • Rensselaer Polytechnic Institute
    Rensselaer Polytechnic InstituteArchitecture, 1969 - 1971

Certifications & Licensure

  • ME State Medical License
    ME State License 2001 - 2025
  • MA State Medical License
    MA State License 1998 - 2003
  • American Board of Oseopathic PhysiciansMedicine
  • American Board of Psychiatry and NeurologyMovement Disorders

Awards, Honors, & Recognition

  • Maine Patients’ Choice Outstanding Physician of the Year, 2008, 2009, 2010, 2011,2012,2013,2014, 2014
  • Honored Speaker AWARD Novartis Pharmaceuticals, 2004
  • Instruction of junior residents and medical students in Neurology Boston University School of Medicine, 1998
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease.  
    C. Warren Olanow, M.D., Olivier Rascol, M.D., Ph.D., Robert Hauser, M.D., Paul D. Feigin, Ph.D., Joseph Jankovic, M.D., Anthony Lang, M.D., William Langston, M.D., E..., New England Journal of Medicine
  • Detection of Cerebral Emboli with Transcranial Doppler Ultrasound.  
    Babikian,V.L., Schwarze, J.J., Drasby E.J, Klingelhofer, J, Journal of Vascular Technology


  • Advances in the Understanding of Parkinson’s Disease. 
    Lebanon, New Hampshire
  • Living with Parkinson’s Disease: How Motor and Non-Motor Symptoms Define the Course of Parkinson’s Disease. 
    Portland, Maine, 2002; Bangor, Maine
  • World Parkinson’s Awareness Day. 
    Mainehealth/American Parkinson’s Disease Association Sponsored
  • Join now to see all


  • Polymorphisms and Expression in SIRT3 are associated with Parkinson disease: the GenePD Study. 
    Nagle MW, BA1; Latourelle JC, DSc2; Lew MF, MD4; Klein C, MD5; Golbe LI, MD6; Mark MH, MD6; Growdon JH, MD7; Wooten GF, MD9; Watts RL, MD10; Litvan I, MD18; Drasby E...
  • Alpha-synuclein and familial Parkinson's disease. 
    Nathan Pankratz, PhD, William C. Nichols, PhD, Veronika E. Elsaesser, BS, Michael W. Pauciulo, MBA, Diane K. Marek, BS, Cheryl A. Halter, MS, Joanne Wojcieszek, MD, ...
  • Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. 
    N. Pankratz, PhD, D. K. Kissell, BS, M. W. Pauciulo, MBA, C. A. Halter, MS, A. Rudolph, PhD, R. F. Pfeiffer, MD, K. S. Marder, MD, T. Foroud, PhD, W. C. Nichols, PhD ...
  • Join now to see all

Professional Memberships